MetaADEDB 2.0 @ LMMD
Perindopril
(IPVQLZZIHOAWMC-QXKUPLGCSA-N)
Structure
SMILES
CCC[C@@H](C(=O)OCC)N[C@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O)C
Type(s)
Approved
ATC code(s)
C09AA04; C09BA04; C09BB04; C09BX01; C09BX02; C10BX11; C10BX12; C10BX13; C10BX14; C10BX15
Molecular Formula:
C19H32N2O5
Molecular Weight:
368.468
Log P:
2.2694
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
2
TPSA:
95.94
CAS Number(s):
82834-16-0; 107133-36-8
Synonym(s)
1.
Perindopril
2.
Perindopril Erbumine
3.
Perstarium
4.
Pirindopril
5.
S 9490-3
6.
S-9490
7.
Erbumine, Perindopril
8.
S 9490
9.
S 9490 3
10.
S 94903
11.
S9490
External Link(s)
MeSHD020913
PubChem Compound40466996
107807
ChEBI8024
CHEMBLCHEMBL1581
DrugBankDB00790
DrugCentral2108
IUPHAR/BPS Guide to PHARMACOLOGY6367
KEGGcpd:C07706
dr:D03753
Therapeutic Target DatabaseD03KYG
ZINC3812867
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AngioedemaFAERS: 9
Canada Vigilance: 24
9485152
16505768
19849764
CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
2DizzinessFAERS: 8
Canada Vigilance: 14
12654706CTD
SIDER
Canada Vigilance
US FAERS
3Drug ineffectiveFAERS: 7
Canada Vigilance: 8
Canada Vigilance
US FAERS
4NauseaFAERS: 6
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
5Blood pressure inadequately controlledFAERS: 4
Canada Vigilance: 8
Canada Vigilance
OFFSIDES
US FAERS
6HypotensionFAERS: 4
Canada Vigilance: 2

View details

CTD
SIDER
Canada Vigilance
US FAERS
7Product use issueFAERS: 4US FAERS
8AnxietyFAERS: 3
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
9ArthralgiaFAERS: 3
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
10ConstipationFAERS: 3SIDER
US FAERS
11General physical health deteriorationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
12HeadacheFAERS: 3
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
13MalaiseFAERS: 3
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
14Memory impairmentFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
15SyncopeFAERS: 3SIDER
US FAERS
16VertigoFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
17VomitingFAERS: 3
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
18AcidosisFAERS: 2OFFSIDES
US FAERS
19Anaphylactoid ReactionFAERS: 2SIDER
US FAERS
20AsthmaFAERS: 2SIDER
US FAERS
21Atrial FibrillationFAERS: 2US FAERS
22Atrioventricular BlockFAERS: 2US FAERS
23Blood creatine phosphokinase increasedFAERS: 2OFFSIDES
US FAERS
24Blood creatinine increasedFAERS: 2SIDER
US FAERS
25Cardiac ArrestFAERS: 2SIDER
US FAERS
26CheilitisFAERS: 2US FAERS
27ConjunctivitisFAERS: 2SIDER
US FAERS
28Cytolytic hepatitisFAERS: 2OFFSIDES
US FAERS
29FatigueFAERS: 2
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
30GingivitisFAERS: 2US FAERS
31Hypertensive crisisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
32Impaired driving abilityFAERS: 2US FAERS
33IncoherentFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
34Intentional product misuseFAERS: 2US FAERS
35Lip swellingFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
36Male sexual dysfunctionFAERS: 2SIDER
US FAERS
37MyalgiaFAERS: 2
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
38PalpitationsFAERS: 2
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
39Rash erythematousFAERS: 2US FAERS
40Respiratory distressFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
41Septic ShockFAERS: 2OFFSIDES
US FAERS
42TinnitusFAERS: 2
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
43Visual ImpairmentFAERS: 2
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
44Abdominal PainFAERS: 1
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
45Acute respiratory failureFAERS: 1US FAERS
46AgitationFAERS: 1SIDER
US FAERS
47AlopeciaFAERS: 1SIDER
US FAERS
48Angina PectorisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
49ArteriosclerosisFAERS: 1US FAERS
50Back PainFAERS: 1SIDER
US FAERS
51BlindnessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
52Blood potassium increasedFAERS: 1US FAERS
53Blood sodium increasedFAERS: 1US FAERS
54Blood urea increasedFAERS: 1SIDER
US FAERS
55Bone painFAERS: 1SIDER
US FAERS
56BronchospasmFAERS: 1SIDER
US FAERS
57Campylobacter infectionFAERS: 1US FAERS
58Cardiac ventricular disorderFAERS: 1US FAERS
59Carotid angioplastyFAERS: 1US FAERS
60CellulitisFAERS: 1US FAERS
61Cerebral cystFAERS: 1US FAERS
62Chest PainFAERS: 1
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
63Chest discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
64CholestasisFAERS: 1US FAERS
65DementiaFAERS: 1US FAERS
66DermatitisFAERS: 1SIDER
US FAERS
67DermatomyositisFAERS: 1OFFSIDES
US FAERS
68Device computer issueFAERS: 1US FAERS
69Diabetic KetoacidosisFAERS: 1US FAERS
70Drug administration errorFAERS: 1US FAERS
71Drug dispensing errorFAERS: 1US FAERS
72Drug prescribing errorFAERS: 1US FAERS
73DyscheziaFAERS: 1US FAERS
74EczemaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
75Epigastric discomfortFAERS: 1US FAERS
76EpilepsyFAERS: 1OFFSIDES
US FAERS
77Erectile dysfunctionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
78Feeling abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
79Flank PainFAERS: 1SIDER
US FAERS
80FlatulenceFAERS: 1SIDER
US FAERS
81Gamma-Glutamyltransferase IncreasedFAERS: 1OFFSIDES
US FAERS
82HordeolumFAERS: 1US FAERS
83HypersensitivityFAERS: 1
Canada Vigilance: 4
Canada Vigilance
US FAERS
84Impaired work abilityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
85Intestinal angioedemaFAERS: 1US FAERS
86LymphadenopathyFAERS: 1US FAERS
87LymphopeniaFAERS: 1US FAERS
88Macular degenerationFAERS: 1US FAERS
89Musculoskeletal PainFAERS: 1US FAERS
90MyositisFAERS: 1US FAERS
91Nephrotic SyndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
92PainFAERS: 1
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
93PancreatitisFAERS: 1
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
94PeritonitisFAERS: 1US FAERS
95PneumoniaFAERS: 1SIDER
US FAERS
96PolyneuropathyFAERS: 1US FAERS
97Posterior reversible encephalopathy syndromeFAERS: 1US FAERS
98Product substitution issueFAERS: 1
Canada Vigilance: 8
Canada Vigilance
US FAERS
99ProteinuriaFAERS: 1
Canada Vigilance: 1
11007831CTD
SIDER
Canada Vigilance
US FAERS
100PruritusFAERS: 1
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
101Pulmonary FibrosisFAERS: 1
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
102QuadriplegiaFAERS: 1US FAERS
103Renal Artery StenosisFAERS: 1US FAERS
104Renal embolismFAERS: 1US FAERS
105Retinal DetachmentFAERS: 1US FAERS
106Retinal Vein OcclusionFAERS: 1US FAERS
107Retinal aneurysmFAERS: 1US FAERS
108RhabdomyolysisFAERS: 1OFFSIDES
US FAERS
109RhinitisFAERS: 1SIDER
US FAERS
110Right ventricular failureFAERS: 1US FAERS
111Sexual DysfunctionFAERS: 1US FAERS
112ShockFAERS: 1SIDER
US FAERS
113Skin UlcerFAERS: 1US FAERS
114Skin reactionFAERS: 1US FAERS
115SomnolenceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
116StomatitisFAERS: 1SIDER
US FAERS
117StressFAERS: 1US FAERS
118SubileusFAERS: 1US FAERS
119Suicide attemptFAERS: 1US FAERS
120Therapy non-responderFAERS: 1US FAERS
121Thrombocytopenic purpuraFAERS: 1US FAERS
122TremorFAERS: 1SIDER
US FAERS
123Urticarial vasculitisFAERS: 1US FAERS
124UrticariaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
125VasculitisFAERS: 1SIDER
US FAERS
126Vitreous DetachmentFAERS: 1US FAERS
127jaundiceFAERS: 1SIDER
US FAERS
128Abdominal discomfortCanada Vigilance: 4Canada Vigilance
129Abdominal tendernessOFFSIDES
130Abnormal visionSIDER
131AcholiaOFFSIDES
132Acute Coronary SyndromeOFFSIDES
SIDER
133Acute kidney injuryCanada Vigilance: 2Canada Vigilance
134AgeusiaOFFSIDES
135AgranulocytosisSIDER
136Albuminuria1998761
12654706
14647892
CTD
137AlveolitisOFFSIDES
138Amaurosis FugaxCanada Vigilance: 1Canada Vigilance
139AmnesiaSIDER
140Amphetamine-Related Disorders20493549CTD
141Anaphylactic shockSIDER
142AnorexiaOFFSIDES
SIDER
143AnuriaOFFSIDES
144Aortic AneurysmOFFSIDES
145Aortic bypassOFFSIDES
146ApathyOFFSIDES
147Arterial restenosisOFFSIDES
148Arteriosclerosis ObliteransOFFSIDES
149Arteritis obliteransOFFSIDES
150ArthritisSIDER
151Aspiration PneumoniaOFFSIDES
152AstheniaCanada Vigilance: 3Canada Vigilance
SIDER
153AthetosisOFFSIDES
154Atrial FlutterOFFSIDES
155Atrial tachycardiaOFFSIDES
156Axonal neuropathyOFFSIDES
157BartholinitisOFFSIDES
158Bile Duct StenosisOFFSIDES
159Bipolar Disorder8529571CTD
160Bladder spasmOFFSIDES
161Blood alkaline phosphatase increasedOFFSIDES
162Blood bilirubin unconjugated increasedOFFSIDES
163Blood creatine increasedCanada Vigilance: 1Canada Vigilance
164Blood gases abnormalOFFSIDES
165Blood glucose decreasedOFFSIDES
166Blood osmolarity decreasedOFFSIDES
167Blood pH increasedOFFSIDES
168Blood pressure fluctuationCanada Vigilance: 1Canada Vigilance
169Blood sodiumOFFSIDES
170Bone marrow depressionOFFSIDES
171BradycardiaOFFSIDES
SIDER
172BronchiectasisOFFSIDES
173BronchitisSIDER
174Burning sensationCanada Vigilance: 1Canada Vigilance
175C-reactive protein abnormalOFFSIDES
176Cardioactive drug levelOFFSIDES
177Cardioactive drug level increasedOFFSIDES
178Cardiomegaly

View details

CTD
179Carotid artery aneurysmOFFSIDES
180Cell DeathOFFSIDES
181Cerebrovascular accidentSIDER
182Chemical and Drug Induced Liver Injury29859236CTD
183Chemotherapeutic drug level increasedOFFSIDES
184ChillsSIDER
185Choking sensationOFFSIDES
186CholangiolitisOFFSIDES
187Chronic left ventricular failureOFFSIDES
188Coagulation factor X level increasedOFFSIDES
189ConfabulationOFFSIDES
190Congenital heart diseaseOFFSIDES
191Contact DermatitisOFFSIDES
192Coronary artery insufficiencyOFFSIDES
193Counterfeit product administeredCanada Vigilance: 1Canada Vigilance
194CyanosisOFFSIDES
195CystOFFSIDES
196Deafness NeurosensoryOFFSIDES
197DehydrationOFFSIDES
198Depressed moodCanada Vigilance: 1Canada Vigilance
199Device interactionOFFSIDES
200Diabetes Mellitus19483504CTD
201Diabetes mellitus inadequate controlOFFSIDES
202Diastolic dysfunctionOFFSIDES
203Diffuse alveolar damageOFFSIDES
204DiscomfortSIDER
205Disease Progression15766818CTD
206Disease recurrenceOFFSIDES
207Disseminated Intravascular CoagulationOFFSIDES
208Diverticular perforationOFFSIDES
209DiverticulosisOFFSIDES
210DrowsinessSIDER
211Dry skinSIDER
212DysgeusiaSIDER
213DyslogiaOFFSIDES
214DyspepsiaCanada Vigilance: 2Canada Vigilance
SIDER
215Dysphonia12670752CTD
OFFSIDES
SIDER
216EcchymosisSIDER
217Ejection Fraction DecreasedOFFSIDES
218Electrocardiogram abnormalSIDER
219Electrocardiogram changeOFFSIDES
220Endocarditis enterococcalOFFSIDES
221Endometrial disorderOFFSIDES
222Endomyocardial Fibrosis14871039
26878793
CTD
223Enlarged uvulaCanada Vigilance: 1Canada Vigilance
224EosinophiliaSIDER
225Eosinophilic PneumoniaSIDER
226Eosinophilic myocarditisOFFSIDES
227EpistaxisOFFSIDES
SIDER
228EructationCanada Vigilance: 1Canada Vigilance
229Erythema MultiformeSIDER
230ErythemaSIDER
231Extremity necrosisOFFSIDES
232Facial NeuralgiaOFFSIDES
233Febrile infectionOFFSIDES
234Feeling ColdCanada Vigilance: 1Canada Vigilance
235FlushingCanada Vigilance: 2Canada Vigilance
SIDER
236FolliculitisOFFSIDES
237FormicationOFFSIDES
238Gastric ulcerOFFSIDES
239GastritisCanada Vigilance: 1Canada Vigilance
240GastroenteritisOFFSIDES
SIDER
241Gastrointestinal PainSIDER
242Gastrointestinal sounds abnormalOFFSIDES
243GlobulinuriaOFFSIDES
244GoutSIDER
245Granulomatous liver diseaseOFFSIDES
246Haptoglobin DecreasedOFFSIDES
247HepatitisSIDER
248Hepatojugular refluxOFFSIDES
249HepatosplenomegalyOFFSIDES
250Herpes LabialisSIDER
251HoarsenessSIDER
252Hypereosinophilic syndromeOFFSIDES
253HyperkinesiaSIDER
254HypogeusiaOFFSIDES
255Inappropriate schedule of product administrationCanada Vigilance: 1Canada Vigilance
256Incision site infectionOFFSIDES
257IncontinenceOFFSIDES
258Incorrect dose administeredCanada Vigilance: 1Canada Vigilance
259Insulin Resistance10923530CTD
260Intermittent ClaudicationSIDER
261Intestinal Diseases16505768CTD
262Intestinal infarctionOFFSIDES
SIDER
263Joint swellingCanada Vigilance: 2Canada Vigilance
264Kidney Diseases19483504CTD
265Kidney FailureOFFSIDES
266LacrimationSIDER
267Left Ventricular HypertrophyOFFSIDES
268LethargyCanada Vigilance: 1Canada Vigilance
269LeukocytosisSIDER
270LeukopeniaSIDER
271Lip and/or oral cavity cancerCanada Vigilance: 1Canada Vigilance
272Lipase increasedCanada Vigilance: 1Canada Vigilance
273Livedo ReticularisOFFSIDES
274Liver Cirrhosis, Experimental

View details

CTD
275Liver Cirrhosis12076858CTD
276Locked-In SyndromeOFFSIDES
277LymphedemaOFFSIDES
278LymphomaOFFSIDES
279Macroglossia9485152CTD
280MalnutritionSIDER
281MeningorrhagiaOFFSIDES
282Metabolic acidosisOFFSIDES
283Metastatic NeoplasmOFFSIDES
284Mood swingsSIDER
285Mouth swellingCanada Vigilance: 1Canada Vigilance
286Muscle WeaknessOFFSIDES
287Muscle necrosisOFFSIDES
288Musculoskeletal discomfortSIDER
289MyelodysplasiaOFFSIDES
290Myocardial Infarction26878793CTD
SIDER
291Myocardial Ischemia11855668CTD
292NasopharyngitisSIDER
293Neck PainSIDER
294Neonatal hypotensionOFFSIDES
295NephritisSIDER
296NephrolithiasisSIDER
297NervousnessSIDER
298NeutropeniaSIDER
299No adverse eventCanada Vigilance: 1Canada Vigilance
300NocturiaSIDER
301OliguriaSIDER
302Oral mucosal exfoliationOFFSIDES
303Oropharyngeal painCanada Vigilance: 1Canada Vigilance
OFFSIDES
304OrthopneaOFFSIDES
305OverweightOFFSIDES
306PallorOFFSIDES
307PancytopeniaSIDER
308PemphigusOFFSIDES
SIDER
309Perceptual distortionsSIDER
310Peripheral swellingCanada Vigilance: 2Canada Vigilance
311Pharyngeal swellingCanada Vigilance: 3Canada Vigilance
312PharyngitisSIDER
313Physical assaultOFFSIDES
314PneumothoraxOFFSIDES
315PolyuriaSIDER
316Prescription drug used without a prescriptionCanada Vigilance: 1Canada Vigilance
317ProctitisOFFSIDES
318Product use in unapproved indicationCanada Vigilance: 1Canada Vigilance
319Protein urine presentSIDER
320Prothrombin level decreasedOFFSIDES
321Prothrombin time ratioSIDER
322PsoriasisSIDER
323Pulmonary EosinophiliaSIDER
324Pulmonary HypertensionOFFSIDES
325Pulmonary arterial pressure increasedOFFSIDES
326Pulmonary function test decreasedOFFSIDES
327PurpuraSIDER
328Raised serum uric acidSIDER
329RalesOFFSIDES
330Reaction to excipientCanada Vigilance: 1Canada Vigilance
331Rectal tenesmusCanada Vigilance: 1Canada Vigilance
332Renal tubular necrosisOFFSIDES
333Respiratory FailureOFFSIDES
334Retinal Artery OcclusionOFFSIDES
335Rheumatoid NoduleOFFSIDES
336SerositisSIDER
337SinusitisSIDER
338SneezingSIDER
339Spermatozoa progressive motility decreasedOFFSIDES
340Stevens-Johnson SyndromeSIDER
341Stomach acheSIDER
342Sudden deathCanada Vigilance: 1Canada Vigilance
OFFSIDES
343SweatingSIDER
344SwellingCanada Vigilance: 1Canada Vigilance
345TachycardiaSIDER
346TensionSIDER
347Therapeutic product effect decreasedCanada Vigilance: 2Canada Vigilance
348Therapeutic response changedCanada Vigilance: 1Canada Vigilance
349ThirstSIDER
350Throat irritationCanada Vigilance: 1Canada Vigilance
351ThrombocytopeniaCanada Vigilance: 1Canada Vigilance
SIDER
352Thrombosis14592556
15626595
CTD
353Transaminases increasedOFFSIDES
354Troponin increasedOFFSIDES
355Upper-airway cough syndromeSIDER
356Urinary IncontinenceSIDER
357Urinary RetentionSIDER
358Urinary tract infectionSIDER
359Urine output increasedSIDER
360Vascular Diseases15076173
15496307
17804673
CTD
361Vascular Remodeling25464244CTD
362Vascular purpuraSIDER
363Vasodilation procedureSIDER
364VasodilationSIDER
365Venous occlusionOFFSIDES
366Ventricular Dysfunction, Left15766818
21516760
26878793
CTD
367Ventricular FibrillationOFFSIDES
368Ventricular Remodeling21516760
26878793
CTD
369nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.